Lia Gore Selected Research

vesencumab

8/2014	A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors.
5/2014	A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lia Gore Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 09/2006
29	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022 - 12/2005
12	Leukemia 11/2021 - 12/2007
7	Neutropenia 10/2018 - 09/2008
6	Disease Progression 01/2021 - 03/2007
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 01/2011
6	Fatigue 01/2019 - 09/2009
6	Nausea 01/2017 - 02/2009
5	Astrocytoma (Pilocytic Astrocytoma) 11/2017 - 09/2006
5	Thrombocytopenia (Thrombopenia) 05/2014 - 09/2008
3	Cytopenia 01/2022 - 06/2013
3	Lymphoma (Lymphomas) 01/2022 - 07/2008
3	Febrile Neutropenia 01/2021 - 02/2009
3	Glioma (Gliomas) 01/2021 - 12/2009
3	Infections 01/2021 - 03/2015
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2020 - 01/2017
3	Melanoma (Melanoma, Malignant) 11/2017 - 09/2006
3	Vomiting 01/2017 - 02/2009
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2016 - 03/2007
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022 - 10/2018
2	Hyperbilirubinemia 01/2022 - 08/2016
2	Philadelphia Chromosome 11/2021 - 01/2021
2	Residual Neoplasm 01/2020 - 12/2016
2	Hodgkin Disease (Hodgkin's Disease) 10/2018 - 01/2016
2	Fever (Fevers) 10/2018 - 09/2009
2	Hematologic Neoplasms (Hematological Malignancy) 09/2018 - 10/2011
2	Pericardial Effusion 01/2018 - 01/2016
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 09/2014
2	Exanthema (Rash) 11/2017 - 08/2014
2	Brain Neoplasms (Brain Tumor) 09/2017 - 05/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2016 - 10/2010
2	Diffuse Intrinsic Pontine Glioma 11/2014 - 06/2013
2	Neuroblastoma 10/2014 - 03/2007
2	Alopecia (Baldness) 05/2014 - 09/2009
2	Bites and Stings (Sting) 01/2014 - 06/2013
2	Glioblastoma (Glioblastoma Multiforme) 06/2013 - 04/2007
2	Osteosarcoma (Osteogenic Sarcoma) 03/2007 - 06/2003
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 11/2021
1	Acute Disease 11/2021
1	Muscular Diseases (Myopathy) 10/2021
1	Sepsis (Septicemia) 01/2021
1	Mucositis 01/2021
1	Down Syndrome (Down's Syndrome) 01/2021

Drug/Important Bio-Agent (IBA)

19	Pharmaceutical PreparationsIBA 01/2022 - 11/2008
8	blinatumomabIBA 01/2022 - 06/2013
6	Biological ProductsIBA 01/2017 - 09/2006
5	AntibodiesIBA 01/2022 - 12/2008
4	entinostat (MS 275)IBA 11/2021 - 07/2008
4	Monoclonal AntibodiesIBA 05/2014 - 06/2008
3	Clofarabine (Clolar)FDA Link 11/2021 - 12/2012
3	Histone Deacetylase InhibitorsIBA 11/2021 - 07/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 12/2012
3	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 02/2009
3	Dasatinib (BMS 354825)FDA Link 01/2018 - 09/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 04/2007
3	Phosphotransferases (Kinase)IBA 05/2015 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 03/2014 - 01/2010
3	Capecitabine (Xeloda)FDA Link 10/2012 - 01/2008
2	Chimeric Antigen ReceptorsIBA 04/2022 - 01/2022
2	Inotuzumab OzogamicinIBA 01/2022 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2016
2	lestaurtinibIBA 05/2021 - 01/2021
2	TabletsIBA 01/2021 - 01/2018
2	Everolimus FDA Link 01/2021 - 01/2018
2	Azacitidine (5 Azacytidine)FDA Link 10/2020 - 01/2018
2	venetoclaxIBA 10/2020 - 09/2018
2	Decitabine FDA Link 01/2020 - 01/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 08/2017
2	CateninsIBA 03/2018 - 03/2014
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2017 - 10/2009
2	Cetuximab (Erbitux)FDA Link 11/2017 - 10/2009
2	ErbB Receptors (EGF Receptor)IBA 11/2017 - 04/2012
2	CytokinesIBA 09/2017 - 06/2013
2	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2016 - 03/2014
2	Messenger RNA (mRNA)IBA 05/2015 - 12/2009
2	Tyrosine Kinase InhibitorsIBA 09/2014 - 04/2012
2	vesencumabIBA 08/2014 - 05/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 09/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010 - 06/2008
2	Proteins (Proteins, Gene)FDA Link 12/2009 - 09/2008
2	Carboplatin (JM8)FDA LinkGeneric 09/2009 - 02/2009
2	phosphomannopentaose sulfateIBA 12/2008 - 09/2006
2	Gefitinib (Iressa)FDA Link 12/2008 - 09/2006
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	CD19 AntigensIBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	Ifosfamide FDA LinkGeneric 10/2021
1	Methotrexate (Mexate)FDA LinkGeneric 10/2020
1	Vorinostat FDA Link 01/2020
1	ProdrugsIBA 01/2020
1	RG7388IBA 01/2020
1	RO6839921IBA 01/2020

Therapy/Procedure

31	Therapeutics 01/2022 - 06/2003
19	Drug Therapy (Chemotherapy) 01/2022 - 06/2008
2	Immunotherapy 01/2022 - 11/2021
2	Hematopoietic Stem Cell Transplantation 01/2022 - 12/2007